Delivery Order SPE2DB20D3111-SPE2DB25FA8FH

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $4,079.03 and a period of performance through July 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S medication. The contract has a firm fixed price and a ceiling value of $56,683.14. The ultimate completion date is May 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has a firm fixed price of $23,061.66 and a performance period ending on May 14, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $6,653.90 and has a completion date of December 27, 2024. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25, a prescription medication, to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a $26,675.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medication, with a performance period through June 27, 2025. This delivery order is issued under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to provide TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has a firm fixed price, with a ceiling value of $7,320.22 and a completion date of June 17, 2025. This delivery order contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,476.50 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has an ultimate completion date of May 17, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,961.81, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication. The award has an ultimate completion date of July 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty medication. The contract has a ceiling value of $2,355.50 and a completion date of July 30, 2024. It is a firm-fixed-price contract, with no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication, with a ceiling value of $19,175.19 and a period of performance through March 19, 2025. This appears to be a firm fixed-price delivery order contract, with no set-aside designation. The contract is part of a larger...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA8FH
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has a firm fixed price of $5,690.68 and a period of performance ending on June 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle held by AmerisourceBergen with the DLA, which allows for the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs. The contract is not designated as a set-aside and is therefore open to general competition.

Generated 9/22/25, 9:47 AM